Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZOMIG Nasal Spray safely and effectively. See full prescribing information for ZOMIG Nasal Spray. ZOMIG® (zolmitriptan) nasal spray Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
ZOMIG Nasal Spray is indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older. Limitations of Use Only use ZOMIG if a clear diagnosis of migraine has been established. If a patient has no response to ZOMIG treatment for the first migraine attack, reconsider the diagnosis of migraine before ZOMIG is administered to treat any subsequent attacks. ZOMIG is not indicated for the prevention of migraine attacks. Safety and effectiveness of ZOMIG have not been established for cluster headache. Not recommended in patients with moderate or severe hepatic impairment [see Dosage and Administration (2.2)].
- generic_name
- zolmitriptan
- product_names
- Zolmitriptan
- ndc
- 64896-083, 64896-083-12, 64896-084, 64896-084-12
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en